Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 1/2001

01-07-2001 | Case Report

Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody

Authors: Takahiro Maeda, Yasuaki Yamada, Masayuki Tawara, Reishi Yamasaki, Yuichi Yakata, Chizuko Tsutsumi, Yasuyuki Onimaru, Simeru Kamihira, Masao Tomonaga

Published in: International Journal of Hematology | Issue 1/2001

Login to get access
Metadata
Title
Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody
Authors
Takahiro Maeda
Yasuaki Yamada
Masayuki Tawara
Reishi Yamasaki
Yuichi Yakata
Chizuko Tsutsumi
Yasuyuki Onimaru
Simeru Kamihira
Masao Tomonaga
Publication date
01-07-2001
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2001
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02982552

Other articles of this Issue 1/2001

International Journal of Hematology 1/2001 Go to the issue

Case Report

Myelodysplastic Syndrome Progresses Rapidly Into Erythroleukemia Associated With Synchronous Double Cancers of the Stomach and the Papilla of Vater

Case Report

A Variant Form of Myelodysplastic Syndrome With Ph− Minor-BCR/ABL Transcript

OriginalPaper

Cytokines in Graft-Versus-Host Disease and the Graft-Versus-Leukemia Reaction

Review Article

Proliferative Capacity of Single Isolated CD34+ Hematopoietic Stem/Progenitor Cells in Paroxysmal Nocturnal Hemoglobinuria

OriginalPaper

Cytokines: Past, Present, and Future

Case Report

Influence of Timing of Administration of 5-Fluorouracil to Donors on Bone Marrow Engraftment in Nonmyeloablated Hosts
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits